Literature DB >> 32930468

Escape of tumor cells from the NK cell cytotoxic activity.

Claudia Cantoni1,2, Hannah Wurzer3,4, Clément Thomas3, Massimo Vitale5.   

Abstract

In recent years, NK cells, initially identified as potent cytotoxic effector cells, have revealed an unexpected complexity, both at phenotypic and functional levels. The discovery of different NK cell subsets, characterized by distinct gene expression and phenotypes, was combined with the characterization of the diverse functions NK cells can exert, not only as circulating cells, but also as cells localized or recruited in lymphoid organs and in multiple tissues. Besides the elimination of tumor and virus-infected cells, these functions include the production of cytokines and chemokines, the regulation of innate and adaptive immune cells, the influence on tissue homeostasis. In addition, NK cells display a remarkable functional plasticity, being able to adapt to the environment and to develop a kind of memory. Nevertheless, the powerful cytotoxic activity of NK cells remains one of their most relevant properties, particularly in the antitumor response. In this review, the process of tumor cell recognition and killing mediated by NK cells, starting from the generation of cytolytic granules and recognition of target cell, to the establishment of the NK cell immunological synapse, the release of cytotoxic molecules, and consequent tumor cell death is described. Next, the review focuses on the heterogeneous mechanisms, either intrinsic to tumors or induced by the tumor microenvironment, by which cancer cells can escape the NK cell-mediated attack. ©2020 Society for Leukocyte Biology.

Entities:  

Keywords:  NK cells; cancer; cytoskeleton; cytotoxicity; immune evasion; immunological synapse

Year:  2020        PMID: 32930468     DOI: 10.1002/JLB.2MR0820-652R

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  7 in total

1.  Intrinsic Resistance of Chronic Lymphocytic Leukemia Cells to NK Cell-Mediated Lysis Can Be Overcome In Vitro by Pharmacological Inhibition of Cdc42-Induced Actin Cytoskeleton Remodeling.

Authors:  Hannah Wurzer; Liza Filali; Céline Hoffmann; Max Krecke; Andrea Michela Biolato; Jérôme Mastio; Sigrid De Wilde; Jean Hugues François; Anne Largeot; Guy Berchem; Jérôme Paggetti; Etienne Moussay; Clément Thomas
Journal:  Front Immunol       Date:  2021-05-24       Impact factor: 7.561

Review 2.  Leveraging NKG2D Ligands in Immuno-Oncology.

Authors:  Mercedes Beatriz Fuertes; Carolina Inés Domaica; Norberto Walter Zwirner
Journal:  Front Immunol       Date:  2021-07-29       Impact factor: 7.561

3.  Targeted integration of EpCAM-specific CAR in human induced pluripotent stem cells and their differentiation into NK cells.

Authors:  Shin Yi Tang; Shijun Zha; Zhicheng Du; Jieming Zeng; Detu Zhu; Yumei Luo; Shu Wang
Journal:  Stem Cell Res Ther       Date:  2021-11-21       Impact factor: 6.832

4.  MICA/B-targeted antibody promotes NK cell-driven tumor immunity in patients with intrahepatic cholangiocarcinoma.

Authors:  Barbara Oliviero; Stefania Varchetta; Dalila Mele; Greta Pessino; Roberta Maiello; Monica Falleni; Delfina Tosi; Matteo Donadon; Cristiana Soldani; Barbara Franceschini; Guido Torzilli; Gaetano Piccolo; Matteo Barabino; Enrico Opocher; Marcello Maestri; Stefano Bernuzzi; Kai W Wucherpfennig; Mario U Mondelli; Stefania Mantovani
Journal:  Oncoimmunology       Date:  2022-02-21       Impact factor: 8.110

5.  N-cadherin protects oral cancer cells from NK cell killing in the circulation by inducing NK cell functional exhaustion via the KLRG1 receptor.

Authors:  Chao Lou; Kailiu Wu; Jianbo Shi; Zhenlin Dai; Qin Xu
Journal:  J Immunother Cancer       Date:  2022-09       Impact factor: 12.469

6.  The MICA-NKG2D axis in clear cell renal cell carcinoma bolsters MICA as target in immuno-oncology.

Authors:  Florencia Secchiari; Sol Yanel Nuñez; Jessica Mariel Sierra; Andrea Ziblat; María Victoria Regge; Ximena Lucía Raffo Iraolagoitia; Agustín Rovegno; Carlos Ameri; Fernando Pablo Secin; Nicolás Richards; Hernando Ríos Pita; Gonzalo Vitagliano; Luis Rico; Mauro Mieggi; Florencia Frascheri; Nicolás Bonanno; Leandro Blas; Aldana Trotta; Adrián David Friedrich; Mercedes Beatriz Fuertes; Carolina Inés Domaica; Norberto Walter Zwirner
Journal:  Oncoimmunology       Date:  2022-08-03       Impact factor: 7.723

Review 7.  Underlying mechanisms of evasion from NK cells as rationale for improvement of NK cell-based immunotherapies.

Authors:  Barbara Seliger; Ulrike Koehl
Journal:  Front Immunol       Date:  2022-08-12       Impact factor: 8.786

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.